A U.S. senator said a GLP-1 drug changed his life — and now he's calling for widespread access to anti-obesity medications.In a New York Times op-ed on April 8, Sen. John Fetterman, D-Pa., wrote about his experience with Mounjaro (tirzepatide).The injectable prescription medicine is primarily used to treat type 2 diabetes. OZEMPIC’S HEALTH BENEFITS KEEP GROWING, BUT ARE THE RISKS WORTH IT?Fetterman was prescribed the medication in July 2025."As a stroke survivor, I was interested in studies showing could significantly reduce the risk of major cardiac events," the senator wrote."Even though I started taking it for my heart health, I’ve been





























